2026Year1Month22Day，Two leading enterprises in the global medical technology field, Medtronic (Medtronic）and MindrayHealthcare（Mindray) announced the expansion of its strategic partnership in patient monitoring technology beyond hospitals to outpatient surgery centers (ASC），This move further strengthens the shared commitment of both parties to support clinicians and patients in inpatient and outpatient settings in the United States.

This time, Medtronic (Medtronic) and Mindray (Mindray）CooperationExpand the strategic partnership for patient monitoring technology beyond hospitals to outpatient surgery centers (ASC），Aimed at simplifying the acquisition and integration process of both parties' advanced monitoring solutions.Both parties expect that this cooperation will help reduce costs, improve clinical outcomes, and enhance the quality of patient care. By integrating resources, outpatient surgery centers can access and utilize advanced monitoring technologies more efficiently, providing patients with higher-quality medical services.

Wayne, President of Mindray North America·Quinn（Wayne Quinn）Indicates:"This expanded collaboration with Medtronic highlights our shared vision – making advanced monitoring technology more accessible across all care settings. As more surgeries shift to outpatient settings, we are proud to provide the advanced monitoring and clinical insights that hospitals rely on, helping ambulatory surgery centers deliver exceptional care efficiently and with confidence."

Blake, Vice President of Medtronic's U.S. Commercial Acute Care and Monitoring·Tatum（Blake Tatum）Weigh:"Regardless of where patients undergo surgery, they should receive reliable, high-quality monitoring. By integrating industry-leading Medtronic technologies such as Microstream™ capnography,BIS™ Brain Monitoring,Nellcor™ Pulse Oximeter andINVOS™ Regional Oximeter Integrated intoMindray's innovative platform, we are making advanced monitoring more accessible in outpatient surgery centers (ASC) in applications, allowing clinicians to focus on patients." This business belongs to part of Medtronic's Medical Surgical portfolio.

The two companies jointly launched a turnkey solution, providing a simplified one-stop service for ambulatory surgery center providers and patients.The solution aims to achieve cost-effectiveness, improve patient outcomes, optimize workflows, enhance clinical training and after-sales support, and streamline procurement processes, comprehensively improving the operational efficiency and medical service standards of outpatient surgery centers.

MindrayNorth America andMedtronicAcute care and monitoring operations have a well-established history of collaboration in the acute care field, particularly with significant achievements in the perioperative environment.MindrayPioneering Integration ofMedtronic BISFour™ Channel Brain Monitoring System withINVOS™ Regional Oximetry Technology enables clinicians to accurately monitor the depth of anesthesia and regional tissue oxygenation in critical care and perioperative settings.

This collaboration pushes highly specialized monitoring technology to the forefront of patient care.MindrayNorth American companies are actively integrating the next generation of Medtronic monitoring technology, including the upcomingINVOS™ 7100Regional Oximeter System and Next GenerationBIS™ Brain Monitoring System, ensuring that clinicians and patients continue to benefit from the most advanced monitoring capabilities.

In addition, the two parties will leverage an integrated distribution network to promote within China's healthcare system.MindrayA more efficient and cost-effective procurement process for monitoring systems (covering all Medtronic technologies).

Mindray North America, as a core component of Mindray's global strategy, has been deeply cultivating the North American market for over30Year, a complete industrial layout covering R&D, production, sales, and services has been formed. With localized operations and technological innovation, the company has become a key player in the medical device industry in North America and globally, particularly taking a leading position in patient monitoring and ultrasound imaging. The North American headquarters is located in Mahwah, New Jersey, the enterprise customer center is in Nashville, Tennessee, and the innovation center is situated in Milpitas, at the heart of Silicon Valley.

2008Year,MindrayAcquiredDatascopePatient monitoring business, which provides more than in operating rooms, emergency care, and intensive care environments.50A variety of patient monitoring devices over the years. Through this acquisition,MindrayHas become the third largest enterprise in the patient monitoring market in North America and globally, as well as the third largest supplier of anesthesia systems.

Five years later,MindrayAcquired the ultrasound technology leader headquartered in Silicon Valley, CaliforniaZonare Medical SystemsThrough this acquisition,MindrayInheritedZonareThrough next-generation software-drivenZONEUltrasound®Technology (ZST) Excellent ultrasound technology.This innovative technology providesMindrayTheLiving TechnologyProvided a platform——this is aSustainable ExpansionThe architecture, to meet the evolving imaging needs of clinicians.

2025Year6Month,MindrayThe warehouse is located in Mahwah, New Jersey.46,314Square feet of expansion project. This project marksMindrayCommitted to advancing infrastructure, better serving healthcare providers and communities, achieving sustainable long-term growth, while remaining dedicated to delivering innovative and accessible healthcare solutions as an important milestone.

Medtronic and Mindray North America are committed to supporting clinicians in various care environments, enhancing patient safety, and expanding the accessibility of high-quality monitoring solutions that meet the evolving needs of the U.S. healthcare system. This collaboration is undoubtedly another significant practice of this commitment.，Instrument之家 will continue to follow up.